Psychedelics Incannex secures financing deal valued at US$60 million It will fund clinical trials that are currently underway and general corporate expenses Rowan DunneSeptember 10, 2024
Lithium Ganfeng Lithium takes Mexico to arbitration over nationalized lithium concession President López Obrador has refused to offer any new mining concessions since taking office in late 2018 Joseph MortonJune 27, 2024
Lithium Albemarle Corporation will hold more lithium auctions to teach investors about the market Lithium's surge in popularity over the past decade has been marred by confusing futures pricing from China Joseph MortonJune 26, 2024
Psychedelics Optimi Health gets psychedelics import permit for Mind Medicine Australia shipment BC's mushroom expert got an MDMA export permit for shipments to Israel this month too Rowan DunneMay 31, 2024
Rare Earths Canada gives Arafura Rare Earths C$408M loan to advance Australian neodymium mine Local mining magnate Gina Rinehart is the company's number one shareholder Rowan DunneMay 27, 2024
Rare Earths Gina Rinehart augments rare earths portfolio with major investment in Australia’s Lynas Australia's wealthiest woman bought 6.6 million more shares valued at over C$35 million Rowan DunneApril 17, 2024
Mining South32 pursues legal action against IGO over royalty dispute Australian mining giants embroiled in court battle over Tropicana gold mine royalties Zartasha MushtaqFebruary 5, 2024
Psychedelics Incannex and partner Clarion open Australia’s first psychedelic therapy clinic in Melbourne Mind Medicine Australia legally dosed the first patients outside of clinical trials in over 50 years last month Rowan DunneFebruary 1, 2024
Alternative Energy The most misunderstood metal: a lithium roundup The strategic importance of lithium in the global economy and geopolitical tensions can contribute to misunderstandings Joseph MortonJanuary 19, 2024
Psychedelics Filament Health ships psilocybin drug to Australia, first country legally prescribing psychedelics The shipment was received by the medical cannabis company Little Green Pharma and its psychedelics subsidiary Rowan DunneJanuary 17, 2024